(MENAFN- GlobeNewsWire - Nasdaq) In the U.S. arteriovenous fistula devices market, opportunities stem from rising ESRD cases, driving demand for AVF solutions. The advanced healthcare system, diabetes and hypertension prevalence, and awareness initiatives bolster growth. AVFs' durability and lower infection rates enhance market potential.

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "U.S. Arteriovenous Fistula Devices Market Size, Share & Trends Analysis Report by Type (AVF Creation Devices, AVF Monitoring Devices, AVF Maintenance Devices), End-use (Hospitals, Ambulatory Surgical Centers, Dialysis Centers), and Growth Forecasts, 2025-2033" report has been added to ResearchAndMarkets's offering.
The U.S. arteriovenous fistula devices market size was estimated at USD 112.0 Million in 2025 and is projected to reach USD 120.0 million by 2033, growing at a CAGR of 0.9% from 2025 to 2033. The growth is attributed to several factors, including the increasing prevalence rate of End-stage Renal Disease (ESRD) and the resulting rise in the number of patients requiring hemodialysis.

The advanced healthcare infrastructure, a high incidence of diabetes & hypertension, and widespread awareness initiatives in the country are expected to drive the market growth. According to 2023 estimates by the Centers for Disease Control and Prevention (CDC), approximately 14% of adults in the U.S. are affected by chronic kidney disease (CKD). Furthermore, the American Kidney Fund reports that approximately 815,000 Americans are currently living with kidney failure, with nearly 555,000 of them undergoing dialysis, highlighting the widespread need for effective treatment solutions.
Due to the critical shortage of kidney donors, the increasing dependence on dialysis underscores the essential role of AVF devices in managing ESRD. The escalating rate of kidney disease is also driving the demand for more advanced and innovative AVF solutions. AV fistulas are preferred for long-term vascular access because of their durability, lower infection rates, and reduced complication risk compared to other access types. These factors are propelling the growth of AVF devices in the U.S.
Two other types of vascular access for hemodialysis, arteriovenous graft (AVG) and central venous catheter (CVC), are the primary substitutes for an arteriovenous fistula. The choice of access has significant clinical and economic implications, directly impacting market dynamics. While AVFs are considered the gold standard due to lower infection rates and better longevity, their long maturation time and high primary failure rate make substitutes necessary.

Why should you buy this report?

• Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
• Competitive Landscape: Explore the market presence of key players.
• Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
• Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Key Attributes:

Report Attribute	Details
No. of Pages	80
Forecast Period	2025 - 2033
Estimated Market Value (USD) in 2025	$112 Million
Forecasted Market Value (USD) by 2033	$120 Million
Compound Annual Growth Rate	0.9%
Regions Covered	United States

U.S. Arteriovenous Fistula Devices Market Variable Trends & Scope

• Market Lineage Outlook
• Parent Market
• Ancillary Market
• Market Dynamics
• Market Driver Analysis
• Market Restraint Analysis
• U.S. Arteriovenous Fistula Devices Market Analysis Tools
• Industry Analysis - Porter's
• PESTEL Analysis

Companies Featured

• Medtronic
• BD
• Teleflex Incorporated
• Fresenius Medical Care
• B. Braun Medical Inc.
• Polymed
• Laminate Medical Technologies Ltd.
• Cook Group
• Smiths Group plc

U.S. Arteriovenous Fistula Devices Market Report Segmentation
Type Outlook (Revenue, USD Million, 2021-2033)

• AVF Creation Devices
• AVF Monitoring Devices
• AVF Maintenance Devices

End-use Outlook (Revenue, USD Million, 2021-2033)

• Hospitals
• Ambulatory Surgical Centers
• Dialysis Centers

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• U.S. Arteriovenous Fistula Devices Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN19112025004107003653ID1110365885